Abbvie Inc
NYSE:ABBV 4:00:00 PM EDT
Products, Strategic Combinations
Abbvie, Frontier Medicines Establish Global Partnership To Discover And Develop Novel Therapies, E3 Degraders Against Difficult-To-Drug Targets
Published: 12/02/2020 13:30 GMT
Abbvie Inc (ABBV) - Abbvie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-drug Targets.
Abbvie Inc - Frontier Eligible to Receive Up to $100 Million in Upfront and Milestone Payments Within First 12 Months of Collaboration.
Abbvie Inc - Will Pay Frontier an Upfront Cash Payment of $55 Million.
Abbvie Inc - Frontier Will Be Eligible to Receive Success-based Development and Commercial Milestone Payments That Could Potentially Exceed $1 Billion.
Abbvie Inc - Frontier Eligible to Receive Up to $100 Million in Upfront and Milestone Payments Within First 12 Months of Collaboration.
Abbvie Inc - Will Pay Frontier an Upfront Cash Payment of $55 Million.
Abbvie Inc - Frontier Will Be Eligible to Receive Success-based Development and Commercial Milestone Payments That Could Potentially Exceed $1 Billion.